{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:29:24Z","timestamp":1790922564082,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is characterized by reproductive disorder and increased risk of metabolic syndrome<jats:bold>.<\/jats:bold> This study aimed to assess the metabolic parameters in the cord blood of neonate of mothers with obese PCOS and comparison with non-obese PCOS and controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective cohort study was conducted in Arash and Kamali Hospital in 2017\u20132018. The biochemical test was conducted on 78 neonates from obese PCOS mothers, 78 neonates from non-obese PCOS mothers, and 78 neonates from healthy mothers. Finally, cord blood lipid profile and insulin and blood sugar were determined by specific kits. Correlations between variables were compared with chi-square, Mann-Whitney\u2019s U, Kruskal-Wallis H tests and regression model by SPSS 23 and <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05 was considered significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Triglycerides (TG) and high-density lipoprotein cholesterol (HDL) were higher in cord blood of newborn of obese PCOS women than non-obese PCOS and controls (<jats:italic>P<\/jats:italic>\u2009=\u20090.02, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, respectively). Also, the mean insulin was higher in cord blood of neonate of non-obese PCOS women than in obese PCOS and controls (12.26\u2009\u00b1\u200912.79 vs. 11.11\u2009\u00b1\u200916.51 vs. 6.21\u2009\u00b1\u200910.66, <jats:italic>P<\/jats:italic>\u2009=\u20090.01). But in the study, there was no significant difference between the mean of umbilical cord low-density lipoprotein cholesterol (LDL), total cholesterol and blood sugar in three groups. The logistic regression model showed that metabolic parameters were related to PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In the present study, there was a significant difference between the mean of umbilical cord HDL, cholesterol, and the insulin level in the three groups. But, there was no significant association between the mean of blood sugar, LDL, and TG in the groups. The metabolic disorder in PCOS might affect cord blood lipid and insulin and adulthood health.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-03697-6","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T13:02:44Z","timestamp":1616245364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metabolic parameters in cord blood of neonate of mothers with obese and non-obese PCOS and controls: retrospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Sanaz","family":"Alizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahideh","family":"Jahanian Sadatmahalleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Razavinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Bahri Khomami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Moini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeideh","family":"Ziaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"issue":"147","key":"3697_CR1","first-page":"159","volume":"27","author":"S Mehrabadi","year":"2017","unstructured":"Mehrabadi S, Jahanian Sadatmahalleh S, Kazemnejad A. Association of depression and anxiety with cognitive function in patients with polycystic ovary syndrome. J Mazandaran Univ Med Sci. 2017;27(147):159\u201370.","journal-title":"J Mazandaran Univ Med Sci"},{"key":"3697_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/jrms.JRMS_804_16","volume":"24","author":"M Akbarzadeh","year":"2019","unstructured":"Akbarzadeh M, Naderi T, Dabbaghmanesh MH. The glucose metabolism disorder and dyslipidemia among girls with different phenotype polycystic ovary syndrome. J Res Med Sci. 2019;24:72.","journal-title":"J Res Med Sci"},{"key":"3697_CR3","unstructured":"Cunningham F, Leveno K, Bloom S, Dashe J, Hoffman B, Casey B, Spong CY. Williams Obstetrics 24\/E: McGraw Hill Professional. New York: McGraw-Hill Education\/Medical; 2018."},{"issue":"4","key":"3697_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jc.2004-1045","volume":"90","author":"EPA ApridonidzeT","year":"2005","unstructured":"ApridonidzeT EPA, Iuorno MJ, Nestle JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. Clin Endocrin Metab. 2005;90(4):1929\u201335.","journal-title":"Clin Endocrin Metab"},{"key":"3697_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","volume":"26","author":"A Gambineri","year":"2002","unstructured":"Gambineri A, Pelusi C, Vicennati V, Pagotto U. Obesity and the polycystic ovary syndrome. Obes Relat Metab Disord. 2002;26:883\u201396.","journal-title":"Obes Relat Metab Disord"},{"key":"3697_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/archpediatrics.2009.3","volume":"163","author":"WD Johnson","year":"2009","unstructured":"Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT. Prevalence of risk factors for metabolic syndrome in adolescents: national health and nutrition examination survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med. 2009;163:371\u20137.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"3697_CR7","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1210\/jc.2009-2651","volume":"95","author":"H Anderson","year":"2010","unstructured":"Anderson H, Fogel N, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J Clin Endocrinol Metab. 2010;95(5):2180\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"3697_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-physiol-020911-153245","volume":"74","author":"P Rinaudo","year":"2012","unstructured":"Rinaudo P, Wang E. Fetal programming and metabolic syndrome. Annu Rev Physiol. 2012;74:107\u201330.","journal-title":"Annu Rev Physiol"},{"key":"3697_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1586\/eci.11.51","volume":"7","author":"NA Hodyl","year":"2011","unstructured":"Hodyl NA, Stark MJ, Osei-Kumah A, Clifton VL. Prenatal programming of the innate immune response following in utero exposure to inflammation: a sexually dimorphic process? Expert Rev Clin Immunol. 2011;7:579\u201392.","journal-title":"Expert Rev Clin Immunol"},{"key":"3697_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1530\/EJE-08-0621","volume":"160","author":"DD Briana","year":"2009","unstructured":"Briana DD, Malamitsi-Puchner A. Intrauterine growth restriction and adult disease: the role of adipocytokines. Eur J Endocrinol. 2009;160:337\u201347.","journal-title":"Eur J Endocrinol"},{"key":"3697_CR11","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138","volume":"93","author":"A Huang","year":"2010","unstructured":"Huang A, Brennan K, Azziz R. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of health 1990 criteria. Fertil Steril. 2010;93:1938\u201341.","journal-title":"Fertil Steril"},{"key":"3697_CR12","unstructured":"Berek JS. Berek & Novak's Gynecology. 15th ed. Tehran: Golban Nashr Company; 2017. p. 1384."},{"issue":"5","key":"3697_CR13","doi-asserted-by":"publisher","first-page":"20316","DOI":"10.1210\/jc.2002-021499","volume":"88","author":"BO Yildiz","year":"2003","unstructured":"Yildiz BO, Yarali H, Oguz H, Bayratar M. Glucose intolerance, insulin resistance, and hyprandrogenemia in first degree relatives of woman with polycystic ovary syndrome. Clin Endocrinol Metab. 2003;88(5):20316.","journal-title":"Clin Endocrinol Metab"},{"issue":"2","key":"3697_CR14","first-page":"34","volume":"14","author":"F Moradi","year":"2011","unstructured":"Moradi F, Akbarzadeh M, Dabbagh Manesh M, Jafari P, Parsa Nejad M. Study of metabolic syndrome in sisters and brothers of women with the syndrome polycystic ovary clinic for women affiliated to shiraz university of medical sciences in 1387. Obset Gynecol. 2011;14(2):34\u201343.","journal-title":"Obset Gynecol"},{"issue":"1","key":"3697_CR15","first-page":"76","volume":"15","author":"F Moradi","year":"2008","unstructured":"Moradi F, Akbarzadeh M, Dabagh Mansheh M, Parsanejad M, Jafari P. Determination of insulin resistance in frist-degree relatives of patients with polycystic ovary syndrome. Yasuj Uni Med Sci. 2008;15(1):76\u201386.","journal-title":"Yasuj Uni Med Sci"},{"issue":"3","key":"3697_CR16","first-page":"5","volume":"12","author":"M Akbarzadeh","year":"2011","unstructured":"Akbarzadeh M, Moradi F, Dabbaghmanesh MH, Jafary P, Parsanezhad ME. A survey of obesity and abnormal glucose tolerance in first degree relatives of women with polycystic ovarian syndrome referred to gynaecology clinics of shiraz university of medical sciences. Yafte. 2011;12(3):5\u201317.","journal-title":"Yafte"},{"issue":"12","key":"3697_CR17","first-page":"242432","volume":"50","author":"JP Bailageon","year":"2007","unstructured":"Bailageon JP, Carpentier AC. Brothers of women with polycystic ovary syndrome are characterized by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia. 2007;50(12):242432.","journal-title":"Diabetologia"},{"issue":"9","key":"3697_CR18","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/humrep\/der197","volume":"26","author":"JA Barry","year":"2011","unstructured":"Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod (Oxford, England). 2011;26(9):2442\u201351.","journal-title":"Hum Reprod (Oxford, England)"},{"key":"3697_CR19","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Con-sensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Con-sensus Workshop Group. Revised 2003 consensuson diagnostic criteria and long-term health risks re-lated to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325.","journal-title":"Fertil Steril"},{"key":"3697_CR20","unstructured":"Mehrabian F, Kelishadi R. Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls. J Res Med Sci. 2012;17(3):207\u201311."},{"issue":"1","key":"3697_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.fertnstert.2008.04.022","volume":"92","author":"M Maliqueo","year":"2009","unstructured":"Maliqueo M, Echiburu B, Crisosto N, Amigo P, Aranda P, Sanchez F, Sir-Peterman T. Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome. Fertil Steril. 2009;92(1):277\u201382.","journal-title":"Fertil Steril"},{"key":"3697_CR22","doi-asserted-by":"publisher","unstructured":"Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940. https:\/\/doi.org\/10.1016\/j.lfs.2019.116940.","DOI":"10.1016\/j.lfs.2019.116940"},{"issue":"10","key":"3697_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002953","volume":"16","author":"NYH Ng","year":"2019","unstructured":"Ng NYH, Jiang G, Cheung LP, Zhang Y, Tam CHT, Luk AOY, et al. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: a case-control study. PLoS Med. 2019;16(10):e1002953. https:\/\/doi.org\/10.1371\/journal.pmed.1002953.","journal-title":"PLoS Med"},{"key":"3697_CR24","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1210\/jc.2003-030044","volume":"88","author":"RS Legro","year":"2003","unstructured":"Legro RS, Azzi R, Ehrmann D, Freshetian AG, O\u2019Keefe M, Ghazzi MN. Minimal responce of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with Troglitazone. Clin Endocrin Metab. 2003;88:5137\u201344.","journal-title":"Clin Endocrin Metab"},{"issue":"5","key":"3697_CR25","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1210\/jc.2007-2256","volume":"93","author":"E Sergio","year":"2008","unstructured":"Sergio E, Recabarren SR, Rios R, Maliqueo M, Echiburu B. Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrin Metab. 2008;93(5):1820\u20136.","journal-title":"J Clin Endocrin Metab"},{"key":"3697_CR26","doi-asserted-by":"publisher","unstructured":"Brouzeng C, Bachelot A, Moriniere C, Vaillant J, Joguet G, Velayoudom FL. Triglycerides as a metabolic target in afrocaribbean infertile women with polycystic ovary syndrome. Metab Syndr Relat Disord. 2019;17(10):500\u20134. https:\/\/doi.org\/10.1089\/met.2019.0041.","DOI":"10.1089\/met.2019.0041"},{"key":"3697_CR27","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, Moncayo S, Insenser M, \u00c1lvarez-Blasco F, Luque-Ram\u00edrez M, Escobar-Morreale HF. Metabolic cytokines at fasting and during macronutrient challenges: influence of obesity, female androgen excess and sex. Nutrients. 2019;11(11):2566. https:\/\/doi.org\/10.3390\/nu11112566. Published 2019 Oct 24.","DOI":"10.3390\/nu11112566"},{"issue":"1","key":"3697_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40292-017-0240-1","volume":"25","author":"LD Elia","year":"2018","unstructured":"Elia LD, Sterazullo P. Excess body weight, insulin resistance and isolated systolic hypertention: potential patophisiological links. High Blood Press Cardiovasc Prev. 2018;25(1):17\u201323.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"12","key":"3697_CR29","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1161\/ATVBAHA.107.153288","volume":"27","author":"NM Hamburg","year":"2007","unstructured":"Hamburg NM, McMackin CJ, Huang AL, Shenouda SM, Widlansky ME, Schulz E. Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers. Arterioscler Thromb Vasc Biol. 2007;27(12):2650\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"3697_CR30","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2337\/diacare.27.2.538","volume":"27","author":"NM McKeown","year":"2004","unstructured":"McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham offspring cohort. Diabetes Care. 2004;27(2):538\u201346.","journal-title":"Diabetes Care"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03697-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-021-03697-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03697-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T13:06:18Z","timestamp":1616245578000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-03697-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3697"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-03697-6","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. On May 23th, 2016, the study was approved by the ethics committee of the Tarbiat Modares University (IR.TMU.REC.1395.367).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"223"}}